HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) A corrigendum has been published All Versions of this Article: 287/4/R886    most recent 00232.2004v1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via ISI Web of Science (7) Citing Articles via Google Scholar Google Scholar Articles by Roos, S. Articles by Jansson, T. Search for Related Content PubMed PubMed Citation Articles by Roos, S. Articles by Jansson, T.

DEVELOPMENTAL PHYSIOLOGY AND PREGNANCY

Human placental taurine transporter in uncomplicated and IUGR pregnancies: cellular localization, protein expression, and regulation

Perinatal Center, Department of Physiology and Pharmacology, Göteborg University, S-405 30 Göteborg, Sweden

Submitted 6 April 2004 ; accepted in final form 25 May 2004

Transplacental transfer is the fetus' primary source of taurine, an essential amino acid during fetal life. In intrauterine growth restriction (IUGR), placental transport capacity of taurine is reduced and fetal taurine levels are decreased. We characterized the protein expression of the taurine transporter (TAUT) in human placenta using immunocytochemistry and Western blotting, tested the hypothesis that placental protein expression of TAUT is reduced in IUGR, and investigated TAUT regulation by measuring the Na⁺-dependent taurine uptake in primary villous fragments after 1 h of incubation with different effectors. TAUT was primarily localized in the syncytiotrophoblast microvillous plasma membrane (MVM). TAUT was detected as a single 70-kDa band, and MVM TAUT expression was unaltered in IUGR. The PKC activator PMA and the nitric oxide (NO) donor 3-morpholinosydnonimine decreased TAUT activity (P < 0.05, n = 7–15). However, none of the tested hormones, e.g., leptin and growth hormone, altered TAUT activity significantly. PKC activity measured in MVM from control and IUGR placentas was not different. In conclusion, syncytiotrophoblast TAUT is strongly polarized to the maternal-facing plasma membrane. MVM TAUT expression is unaltered in IUGR, suggesting that the reduced MVM taurine transport in IUGR is due to changes in transporter activity. NO release downregulates placental TAUT activity, and it has previously been shown that IUGR is associated with increased fetoplacental NO levels. NO may therefore play an important role in downregulating MVM TAUT activity in IUGR.

fetal growth; hormones; nitric oxide; placental transport; phorbol 12-myristate 13-acetate

This article has been cited by other articles:

				S. Roos, N. Jansson, I. Palmberg, K. Saljo, T. L. Powell, and T. Jansson Mammalian target of rapamycin in the human placenta regulates leucine transport and is down-regulated in restricted fetal growth J. Physiol., July 1, 2007; 582(1): 449 - 459. [Abstract] [Full Text] [PDF]

				C. G. Iruloh, S. W. D'Souza, P. F. Speake, I. Crocker, W. Fergusson, P. N. Baker, C. P. Sibley, and J. D. Glazier Taurine transporter in fetal T lymphocytes and platelets: differential expression and functional activity Am J Physiol Cell Physiol, January 1, 2007; 292(1): C332 - C341. [Abstract] [Full Text] [PDF]

				P. Settle, C. P. Sibley, I. M. Doughty, T. Johnston, J. D. Glazier, T. L. Powell, T. Jansson, and S. W. D'Souza Placental Lactate Transporter Activity and Expression in Intrauterine Growth Restriction Reproductive Sciences, July 1, 2006; 13(5): 357 - 363. [Abstract] [PDF]